Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial

著者: Nathalie Baize, I. Monnet, Laurent Greillier, Margaux Geier, H. Léna, Henri Janicot, A. Vergnenègre, Jacky Créquit, R. Lamy, J.B. Auliac, J. Letreut, H. Le Caer, Radj Gervais, Éric Dansin, Anne Madroszyk, P Renault, G. Le Garff, L. Falchero, H. Bérard, Roland Schött, Patrick Saulnier, C. Chouaïd - The Lancet 2020 被引用: 153